 Low allergenicity clonidine impedes studies sensitization mechanisms guinea pig models clinical trials clonidine transdermal device clonidine-specific allergic contact dermatitis patients treatment period year different guinea pig strains development experimental guinea pig model in-depth studies mechanism sensitization possible role transdermal device components Transient low-level clonidine allergy minority animals severe sensitization procedures epicutaneous applications intradermal adjuvant FCA injections Sensitization additional booster procedures cyclophosphamide pretreatment putative cofactors UV-treatments parvum involvement results persistent skin contacts man transdermal devices sustained drug delivery generate unique conditions development allergic contact dermatitis difficult experimental animal models clinical allergy weak drugs available predictive contact allergy animal models Clinical studies unavoidable factors sensitization rates acceptable levels